These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34314790)

  • 1. Alginate-azo/chitosan nanocapsules in vitro drug delivery for hepatic carcinoma cells: UV-stimulated decomposition and drug release based on trans-to-cis isomerization.
    Chen Q; Li X; Xie Y; Hu W; Cheng Z; Zhong H; Zhu H
    Int J Biol Macromol; 2021 Sep; 187():214-222. PubMed ID: 34314790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azo modified hyaluronic acid based nanocapsules: CD44 targeted, UV-responsive decomposition and drug release in liver cancer cells.
    Chen Q; Li X; Xie Y; Hu W; Cheng Z; Zhong H; Zhu H
    Carbohydr Polym; 2021 Sep; 267():118152. PubMed ID: 34119127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
    Qu J; Zhao X; Ma PX; Guo B
    Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma.
    Zhou X; Zhang M; Yung B; Li H; Zhou C; Lee LJ; Lee RJ
    Int J Nanomedicine; 2012; 7():5465-74. PubMed ID: 23093902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Layer-by-layer development of chitosan/alginate-based platelet-mimicking nanocapsules for augmenting doxorubicin cytotoxicity against breast cancer.
    Ibrahim A; Khalil IA; Mahmoud MY; Bakr AF; Ghoniem MG; Al-Farraj ES; El-Sherbiny IM
    Int J Biol Macromol; 2023 Jan; 225():503-517. PubMed ID: 36403763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin.
    Yu J; Xie X; Zheng M; Yu L; Zhang L; Zhao J; Jiang D; Che X
    Int J Nanomedicine; 2012; 7():5079-90. PubMed ID: 23049255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations.
    Yousefpour P; Atyabi F; Farahani EV; Sakhtianchi R; Dinarvand R
    Int J Nanomedicine; 2011; 6():1487-96. PubMed ID: 21796249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin.
    Chen CK; Wang Q; Jones CH; Yu Y; Zhang H; Law WC; Lai CK; Zeng Q; Prasad PN; Pfeifer BA; Cheng C
    Langmuir; 2014 Apr; 30(14):4111-9. PubMed ID: 24665861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.
    Wang F; Yang S; Yuan J; Gao Q; Huang C
    J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy.
    Guo H; Lai Q; Wang W; Wu Y; Zhang C; Liu Y; Yuan Z
    Int J Pharm; 2013 Jul; 451(1-2):1-11. PubMed ID: 23618965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
    Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
    Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of galactosylated glycol chitosan micelles and its potential use for hepatoma-targeting delivery of doxorubicin.
    Yu JM; Li WD; Lu L; Zhou XY; Wang DY; Li HM; Xu XY; Chen J
    J Mater Sci Mater Med; 2014 Mar; 25(3):691-701. PubMed ID: 24338380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering pectin-based hollow nanocapsules for delivery of anticancer drug.
    Ji F; Li J; Qin Z; Yang B; Zhang E; Dong D; Wang J; Wen Y; Tian L; Yao F
    Carbohydr Polym; 2017 Dec; 177():86-96. PubMed ID: 28962799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer.
    Lu S; Xu L; Kang ET; Mahendran R; Chiong E; Neoh KG
    Eur J Pharm Sci; 2016 Mar; 84():103-15. PubMed ID: 26780592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Layer-by-layer assembled decomposable nanocapsules for light-responsive release of pesticide imidacloprid on Aphis craccivora Koch.
    Gao Y; Xiao W; Gu C; Yu S; Li S; Zou A
    Pest Manag Sci; 2024 Jul; 80(7):3207-3214. PubMed ID: 38353377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy.
    Safari Sharafshadeh M; Tafvizi F; Khodarahmi P; Ehtesham S
    Int J Biol Macromol; 2023 Apr; 235():123686. PubMed ID: 36801304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
    Wang C; Wei X; Shao G
    Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of Doxorubicin in Furcellaran/Chitosan Nanocapsules by Layer-by-Layer Technique for Selectively Controlled Drug Delivery.
    Milosavljevic V; Jamroz E; Gagic M; Haddad Y; Michalkova H; Balkova R; Tesarova B; Moulick A; Heger Z; Richtera L; Kopel P; Adam V
    Biomacromolecules; 2020 Feb; 21(2):418-434. PubMed ID: 31738540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Abo Mansour HE; El-Batsh MM; Badawy NS; Mehanna ET; Mesbah NM; Abo-Elmatty DM
    Hum Exp Toxicol; 2020 Nov; 39(11):1528-1544. PubMed ID: 32519553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma.
    Wang QS; Gao LN; Zhu XN; Zhang Y; Zhang CN; Xu D; Cui YL
    Theranostics; 2019; 9(21):6239-6255. PubMed ID: 31534548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.